logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Intestinal alkaline phosphatase Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
LevamisoleIC505000.0 [1], 20210.0 [2], 200000.0 [3], 400000.0 [4]
PhenylalanineIC505000.0 [1], 80200.0 [2], 100000.0 [3]
6-(1-Benzothiophen-2-yl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole;hydrochlorideIC50400000.0 [1]
2-(5,6-Dihydroimidazo[2,1-b][1,3]thiazol-6-yl)-1-benzothiophen-5-amine;hydrochlorideIC50400000.0 [1]
6-(1-Benzothiophen-2-yl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochlorideIC50400000.0 [1]

Rows per page:

1–5 of 94

References
This online resource may be cited as follows
MLA
"Quest Database™ Intestinal alkaline phosphatase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 5 Dec. 2025, https://www.aatbio.com/data-sets/intestinal-alkaline-phosphatase-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025, December 5). Quest Database™ Intestinal alkaline phosphatase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/intestinal-alkaline-phosphatase-inhibitors-ic50-ki.
BibTeXEndNoteRefMan